51 related articles for article (PubMed ID: 1875910)
1. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily.
Bornheim LM; Correia MA
Mol Pharmacol; 1991 Aug; 40(2):228-34. PubMed ID: 1875910
[TBL] [Abstract][Full Text] [Related]
2. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol.
Bornheim LM; Correia MA
Mol Pharmacol; 1990 Sep; 38(3):319-26. PubMed ID: 2402224
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol.
Bornheim LM; Correia MA
Mol Pharmacol; 1989 Sep; 36(3):377-83. PubMed ID: 2779523
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
5. Microsomal alcohol oxygenase: purification and characterization of a cytochrome P450 responsible for oxidation of 7-hydroxy-delta 8-tetrahydrocannabinol to 7-oxo-delta 8-tetrahydrocannabinol in guinea pig liver.
Matsunaga T; Tanaka H; Komura A; Watanabe K; Yamamoto I; Yoshimura H
Arch Biochem Biophys; 1997 Dec; 348(1):56-64. PubMed ID: 9390174
[TBL] [Abstract][Full Text] [Related]
6. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T
Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823
[TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
8. A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization.
Sakamoto K; Kirita S; Baba T; Nakamura Y; Yamazoe Y; Kato R; Takanaka A; Matsubara T
Arch Biochem Biophys; 1995 Jun; 319(2):372-82. PubMed ID: 7786018
[TBL] [Abstract][Full Text] [Related]
9. Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol.
Bornheim LM; Lasker JM; Raucy JL
Drug Metab Dispos; 1992; 20(2):241-6. PubMed ID: 1352216
[TBL] [Abstract][Full Text] [Related]
10. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver.
Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H
Drug Metab Dispos; 1988; 16(6):880-9. PubMed ID: 2907469
[TBL] [Abstract][Full Text] [Related]
11. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
Powell PK; Wolf I; Lasker JM
Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
[TBL] [Abstract][Full Text] [Related]
12. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
13. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
Prough RA; Brown MI; Dannan GA; Guengerich FP
Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
[TBL] [Abstract][Full Text] [Related]
14. A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes.
Watanabe K; Narimatsu S; Matsunaga T; Yamamoto I; Yoshimura H
Biochem Pharmacol; 1993 Aug; 46(3):405-11. PubMed ID: 8394082
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of human liver microsomal cytochrome P-450 2A6.
Yun CH; Shimada T; Guengerich FP
Mol Pharmacol; 1991 Nov; 40(5):679-85. PubMed ID: 1944238
[TBL] [Abstract][Full Text] [Related]
16. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation.
Clarke L; Waxman DJ
Cancer Res; 1989 May; 49(9):2344-50. PubMed ID: 2706622
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450.
Kokkinakis DM; Koop DR; Scarpelli DG; Coon MJ; Hollenberg PF
Cancer Res; 1985 Feb; 45(2):619-24. PubMed ID: 3967237
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
19. Identification of cytochrome P-450 isozymes involved in the hydroxylation of dantrolene by rat liver microsomes.
Jayyosi Z; Villoutreix J; Ziegler JM; Batt AM; De Maack F; Siest G; Thomas PE
Drug Metab Dispos; 1993; 21(5):939-45. PubMed ID: 7902259
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the metabolism of cannabinoids.
Yamamoto I; Watanabe K; Narimatsu S; Yoshimura H
Int J Biochem Cell Biol; 1995 Aug; 27(8):741-6. PubMed ID: 7584607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
